I can't definitively say that it's the PP holders selling, but that's a reasonable conclusion. If so, it's disappointing that they are price indiscriminate. Their cost basis may be low, but they're leaving a LOT on the table.
Absolutely, those three tickers you mentioned all ran wild on much higher floats and O/S - Bodes well for $NXEN and the PPS possibilities here, I'm accumulating and holding tight - Finally averaged down under $.49 and will add more as I see fit..
As you mentioned, the selling will soon stop and we'll most likely have a solid base formed in the $.50's - Won't take much buying pressure to get this back over $1.00+.
Expecting to hear more about their clinical use of a Cannabinoid-Based Formulation for the treatment of Myotonic Dystrophies and Myotonia
Another FORM 3 filed and new VP of Corporate Development, Frank Manganella, has 2.42M restricted shares - I'm banking on them putting on some press releases within the next several weeks now that the "Team" has been established.
News 
Market Data 
Discover 
